De biologie van geluk

Geluk is iets ongrijpbaar, tijdelijk en toch is het een ontzettend sterk gevoel. Zo sterk dat het samen met een goede gezondheid onze grootste wens is. Psychologen zullen vertellen wat de voorwaarden zijn om een gelukkig leven te leiden. Maar wat men ook doet, als de hersenen falen in het activeren van de gelukshormonen, blijft het gevoel gelukkig te zijn achterwege. Dit verklaart waarom mensen die alles hebben om gelukkig te zijn, zich tekort gedaan voelen. Dit artikel gaat over de biologische dynamiek van geluk.

Beste bezoeker, u heeft geen toegang.

Enkel (web)abonnees hebben toegang tot tijdschriftartikelen. Het webabonnement is nog in de maak.

U kunt zich wel alvast (gratis) registreren en tal van andere webartikelen raadplegen!

Verschenen in

Referenties

  1. Hirose N. et al. Interactions among mu- and delta-opioid receptors, especially putative delta1-and delta2-opioid receptors, promote dopamine release in the nucleus accumbens. Neuroscience. 2005.

  2. Spanagel R. et al. Beta-endorphin-induced locomotor stimulation and reinforcement are associated with an increase in dopamine release in the nucleus accumbens. Psychopharmacology (Berl). 1991.

  3. Leonid Yavich. et al. Site-Specific Role of Catechol-O-Methyltransferase in Dopamine Overflow within Prefrontal Cortex and Dorsal Striatum. The Journal of Neuroscience, 2007.

  4. Köseoglu E. et al. Aerobic exercise and plasma beta endorphin levels in patients with migrainous headache without aura. Cephalalgia. 2003.

  5. Minoru Narita. et al. Direct Involvement of Orexinergic Systems in the Activation of the Mesolimbic Dopamine Pathway and Related Behaviors Induced by Morphine. The Journal of Neuroscience, January 11, 2006• 26(2):398–405.

  6. Hirose N. et al. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens. Neuroscience. 2005;135(1):213-25.

  7. Chen N. en Reith ME. Structure and function of the dopamine transporter. Eur J Pharmacol. 2000 Sep 29;405(1-3):329-39.

  8. Sylvie Tordjman et al. Pain Reactivity and Plasma b-Endorphin in Children and Adolescents with Autistic Disorder. PLoS ONE | www.plosone.org 1 August 2009 | Volume 4 | Issue 8 | e5289.

  9. Ream Al-Hasani et al. Molecular Mechanisms of Opioid Receptor-Dependent Signaling and Behavior. Anesthesiology. 2011 Dec; 115(6): 1363–1381.

  10. Johnson PM. et al. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci. 2010 May;13(5):635-41. doi: 10.1038/nn.2519. Epub 2010 Mar 28.

  11. Appleyard SM. et al. A role for the endogenous opioid beta-endorphin in energy homeostasis. Endocrinology. 2003 May;144(5):1753-60.

  12. Nicole M. Avena. et al. Evidence for sugar addiction: Behavioral and neurochemical effects of intermittent, excessive sugar intake.

  13. Cook EH Jr. et al. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet. 1995 Apr;56(4):993-8.

  14. Patrick O. McGowan et al. Diet and the epigenetic (re)programming of phenotypic differences in behavior. rain Res. 2008 October 27; 1237: 12–24. doi:10.1016/j.brainres.2008.07.074.

  15. E Stice et al. Weight Gain is Associated with Reduced Striatal Response to Palatable Food. J Neurosci. 2010 September 29; 30(39): 13105–13109. doi:10.1523/JNEUROSCI.2105-10.2010.

  16. Krause J. et al. SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder. Expert Rev Neurother. 2008 Apr;8(4):611-25. doi: 10.1586/14737175.8.4.611.

  17. Paul M. Johnson et al. Addiction-like reward dysfunction and compulsive eating in obese rats: Role for dopamine D2 receptors. Nat Neurosci. 2010 May ; 13(5): 635–641. doi:10.1038/nn.2519.

  18. Amy S. Leonardson et al. The effect of food intake on gene expression in human peripheral blood. Human Molecular Genetics, 2010, Vol. 19, No. 1 159–169 doi:10.1093/hmg/ddp476. Advance Access published on October 16, 2009.

  19. Niikura K. et al. Neuropathic and chronic pain stimuli downregulate central mu-opioid and dopaminergic transmission. Trends Pharmacol Sci. 2010 Jul;31(7):299-305. Epub 2010 May 12.

  20. Alsiö J. et al. Dopamine D1 receptor gene expression decreases in the nucleus accumbens upon long-term exposure to palatable food and differs depending on diet-induced obesity phenotype in rats. Neuroscience. 2010 Dec 15;171(3):779-87. doi: 10.1016/j.neuroscience.2010.09.046. Epub 2010 Sep 26.

  21. Elias AN. et al. Relationship between beta-endorphin/beta-lipotropin, hyperglycemia, and hyperinsulinemia in obese male Zucker rats. Proc Soc Exp Biol Med. 1989 Nov;192(2):157-60.

  22. Pradeep J. Nathan et al. From taste hedonics to motivational drive: central m-opioid receptors and binge-eating behaviour.

  23. Leandro F. Vendruscolo et al. Sugar Overconsumption during Adolescence Selectively Alters Motivation and Reward Function in Adult Rats. PLoS ONE | www.plosone.org 1 February 2010 | Volume 5 | Issue 2 | e9296.

  24. Andre L. Curtis. et al. Evidence for Functional Release of Endogenous Opioids in the Locus Ceruleus during Stress Termination. Society for Neuroscience 0270-6474/01/210001.

  25. Cooper SJ. et al. Endorphins and food intake: kappa opioid receptor agonists and hyperphagia. Pharmacol Biochem Behav. 1985 Nov;23(5):889-901.

  26. Touzani, K., R.J. Bodnar and A. Sclafani. "Acquisition of Glucose-conditioned Flavor Preference Requires the Activation of Dopamine D1-like Receptors Within the Medial Prefrontal Cortex in Rats." Neurobiology of Learning and Memory 94: 214-19. (Books and Publications: Peer Reviewed Article) 2010

  27. Ong ZY. et al. Maternal "junk-food" feeding of rat dams alters food choices and development of the mesolimbic reward pathway in the offspring. FASEB J. 2011 Jul;25(7):2167-79. doi: 10.1096/fj.10-178392. Epub 2011 Mar 22.

  28. Vucetic Z. et al. Maternal high-fat diet alters methylation and gene expression of dopamine and opioid-related genes. Endocrinology. 2010 Oct;151(10):4756-64. Epub 2010 Aug 4.

  29. Del Arbol JL. et al. [Plasma concentrations of beta-endorphins in the children of alcoholic patients]. An Med Interna. 2007 Jun;24(6):273-7.

  30. Marta Skrundz et al. Plasma Oxytocin Concentration during Pregnancy is associated with Development of Postpartum Depression. Neuropsychopharmacology (2011) 36, 1886–1893.

  31. Eapen V. et al. Separation anxiety, attachment and inter-personal representations: disentangling the role of oxytocin in the perinatal period. PLoS One. 2014 Sep 17;9(9):e107745. doi: 10.1371/journal.pone.0107745. eCollection 2014.

  32. Kurth L, Haussmann R. Perinatal Pitocin as an early ADHD biomarker: neurodevelopmental risk? J Atten Disord. 2011 JuI;15(5):423-31. Epub 2011 Apr 28.

  33. Le Merrer J. et al. Reward processing by the opioid system in the brain. Physiol Rev. 2009 Oct;89(4):1379-412. doi: 10.1152/physrev.00005.2009.

  34. Drolet G. et al. Role of endogenous opioid system in the regulation of the stress response. og Neuropsychopharmacol Biol Psychiatry. 2001 May;25(4):729-41.

  35. Adam S Sprouse-Blum et al. Understanding Endorphins and Their Importance in Pain Management. Hawaii Med J. Mar 2010.

  36. Akanji AO. et al. Plasma and salivary concentrations of glucose and cortisol during insulin-induced hypoglycaemic stress in healthy Nigerians. Afr J Med Med Sci. 1990.

  37. Brian A Baldo et al. Upregulation of Gene Expression in Reward-Modulatory Striatal Opioid Systems by Sleep Loss. Neuropsychopharmacology. 2013 Dec; 38(13): 2578–2587.

  38. John T. Williams et al. Cellular and Synaptic Adaptations Mediating Opioid Dependence. Physiol Rev. 2001 Jan;81(1):299-343.

  39. Robert H. Pietrzak et al. Association of In Vivo κ-Opioid Receptor Availability and the Transdiagnostic Dimensional Expression of Trauma-Related Psychopathology. JAMA Psychiatry. 2014;71(11):1262-1270. doi:10.1001/jamapsychiatry.2014.1221.

  40. Li Chen et al. The opioid peptide dynorphin directly blocks NMDA receptor channels in the rat. Journal of Physiology (1995), 482.3, pp. 575-581.

  41. Gulat­Marnay C. et al. Modulation of histamine release in the rat brain by kappa­opioid receptors. J Neurochem. 1990 Jul;55(1):47­53.

  42. Anna Kloda et al. Adenosine Triphosphate Acts as Both a Competitive Antagonist and a Positive Allosteric Modulator at Recombinant N-Methyl-D-aspartate Receptors. Mol Pharmacol 65:1386–1396, 2004.

  43. Whitney S. Powell et al. An NMDA Antagonist Impairs Copulation and the Experience-Induced Enhancement of Male Sexual Behavior in the Rat. Behav Neurosci. 2003 Feb;117(1):69-75.

  44. Yasuo Morimoto et al. Effects of Memantine, an N-Methyl-D-aspartate Receptor Antagonist, on Fatigue and Neuronal Brain Damage in a Rat Model of Combined (Physical and Mental) Fatigue. Biol. Pharm. Bull. 35(4) 481–486 (2012).

  45. Martin L. Pall. Elevated Nitric Oxide/Peroxynitrite Theory of Multiple Chemical Sensitivity: Central Role of N-Methyl-D-Aspartate Receptors in the Sensitivity Mechanism. Environmental Health Perspectives • VOLUME111 | NUMBER12 | September 2003.

  46. Xu RK. et al. [Role of central endogenous dynorphin in control of ACTH and prolactin release during resting and stress]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1990 Jun;12(3):178-81.

  47. Yu-Jhen Huang et al. NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer’s Disease. Current Neuropharmacology, 2012, 10, 272-285.

  48. Ahmed I. et al. Glutamate NMDA receptor dysregulation in Parkinson's disease with dyskinesias. Brain. 2011 Apr;134(Pt 4):979-86. doi: 10.1093/brain/awr028. Epub 2011 Mar 2.

  49. Andras Bilkei-Gorzo et al. Dynorphins Regulate Fear Memory: from Mice to Men. The Journal of Neuroscience, July 4, 2012• 32(27):9335–9343 • 9335.

  50. T Deckersbach et al. Pilot randomized trial demonstrating reversal of obesity-related abnormalities in reward system responsivity to food cues with a behavioral intervention. Nutrition & Diabetes (2014) 4, e129; doi:10.1038/nutd.2014.26.